Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Manual Proposed by the Japan Society of Hepatology

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death not only in Japan but worldwide. Clinical Practice Guidelines for HCC were published in 2001 by the European Society of Study of the Liver (EASL) and in 2005 by the American Association for the Study of Liver Disease (AASLD). However, these guidelines have proven to be somewhat unsuitable for Japanese patients. In 2005, supported by the Japanese Ministry of Health, Labor and Welfare, Evidence-Based Clinical Practice Guidelines for HCC were compiled. Based on ‘evidence-based’ guidelines and the consensus of an expert panel on HCC, the Japan Society of Hepatology (JSH) published the Consensus-Based Clinical Practice Manual in 2007. In this article, the content of this manual, especially issues on surveillance, diagnosis, staging, and treatment, is summarized.

[1]  PhD Masatoshi Kudo MD.  Contrast Harmonic Imaging in the Diagnosis and Treatment of Hepatic Tumors , 2003, Springer Japan.

[2]  V. Vilgrain,et al.  Small Nodule Detection in Cirrhotic Livers: Evaluation with US, Spiral CT, and MRI and Correlation with Pathologic Examination of Explanted Liver , 2001, Journal of computer assisted tomography.

[3]  M. Kudo.  Imaging Diagnosis of Hepatocellular Carcinoma and Premalignant/Borderline Lesions , 1999, Seminars in liver disease.

[4]  Evaluation of hepatocellular carcinoma after treatment with transcatheter arterial chemoembolization: comparison of Lipiodol-CT, power Doppler sonography, and dynamic MRI , 2001 .

[5]  F. Callea,et al.  Pathology of hepatocellular carcinoma , 1993, Journal of surgical oncology. Supplement.

[6]  O. Matsui,et al.  Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material. , 2002, Radiology.

[7]  J W Marsh,et al.  Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation. , 2000, Radiology.

[8]  J. Bruix,et al.  Prospective Validation of the Cancer of the Liver Italian Program (CLIP) Score: A New Prognostic System for Patients With Cirrhosis and Hepatocellular Carcinoma , 2000, Hepatology.

[9]  O. Matsui,et al.  Hypervascular hepatocellular carcinoma: evaluation of hemodynamics with dynamic CT during hepatic arteriography. , 1998, Radiology.

[10]  M. Schwartz,et al.  Detection of hepatocellular carcinoma in cirrhotic patients: sensitivity of CT and ultrasonography. , 1996, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[11]  S. Hirohashi,et al.  Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. , 1991, Human pathology.

[12]  N. Izumi,et al.  Assessment of Kupffer cells by ferumoxides-enhanced MR imaging is beneficial for diagnosis of hepatocellular carcinoma: comparison of pathological diagnosis and perfusion patterns assessed by CT hepatic arteriography and CT arterioportography. , 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

[13]  H. Imamura,et al.  Value of Lipiodol Computed Tomography and Digital Subtraction Angiography in the Era of Helical Biphasic Computed Tomography as Preoperative Assessment of Hepatocellular Carcinoma , 2001, Annals of surgery.

[14]  M. Makuuchi,et al.  Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients , 2005, Gut.

[15]  H. Honda,et al.  Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation. , 2002, AJR. American journal of roentgenology.

[16]  H. Hasegawa,et al.  Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients , 1985, Cancer.

[17]  Masatoshi Kudo,et al.  Validation of a new prognostic staging system for hepatocellular carcinoma: The JIS score compared with the CLIP score , 2004, Hepatology.

[18]  H. Shinmoto,et al.  Superparamagnetic iron oxide-enhanced MR imaging for focal hepatic lesions: a comparison with CT during arterioportography plus CT during hepatic arteriography , 2005, Journal of Gastroenterology.

[19]  L Pagliaro,et al.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.

[20]  M. Makuuchi,et al.  Dissemination of evidence-based clinical practice guidelines for hepatocellular carcinoma among Japanese hepatologists, liver surgeons and primary care physicians , 2007, Gut.

[21]  T. Murakami,et al.  Superparamagnetic iron oxide–enhanced magnetic resonance images of hepatocellular carcinoma: Correlation with histological grading , 2000, Hepatology.

[22]  J. Bruix,et al.  Management of hepatocellular carcinoma , 2005, Hepatology.

[23]  D. Yoshida,et al.  Evaluation of hepatocellular carcinoma after treatment with transcatheter arterial chemoembolization: comparison of Lipiodol-CT, power Doppler sonography, and dynamic MRI , 2001, Abdominal Imaging.

[24]  N. Chalasani,et al.  Screening for hepatocellular carcinoma in patients with advanced cirrhosis , 1999, American Journal of Gastroenterology.

[25]  S. Hirohashi,et al.  Natural history and prognosis of adenomatous hyperplasia and early hepatocellular carcinoma: multi-institutional analysis of 53 nodules followed up for more than 6 months and 141 patients with single early hepatocellular carcinoma treated by surgical resection or percutaneous ethanol injection. , 1998, Japanese journal of clinical oncology.

[26]  K. Koh,et al.  Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic livers: accuracy of helical CT in transplant patients. , 2000, AJR. American journal of roentgenology.

[27]  M. Makuuchi,et al.  A modified Japan Integrated Stage score for prognostic assessment in patients with hepatocellular carcinoma , 2006, Journal of Gastroenterology.

[28]  M. Kudo,et al.  Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio. , 2004, AJR. American journal of roentgenology.

[29]  M. Kudo,et al.  Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score) , 2003, Journal of Gastroenterology.

[30]  J. Bruix,et al.  Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification , 1999, Seminars in liver disease.

[31]  M. Makuuchi,et al.  Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan. , 2006, World journal of gastroenterology.

[32]  Bellia Mario,et al.  Prospective validation of the CLIP score, a new prognostic system for cirrhotic patients with hepatocellular carcinoma (RE: Hepatology 2000, 32/3: 679-80) , 2000 .